Showing results (311-320 of 335) with videos related to

Sort By:
Pageof 34
Oncogene|November 24, 2015
Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cellsS Diersch, M Wirth, C Schneeweis, et al.
European Radiology|February 20, 2015
Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decadeMichael B Pitton, Evelyn Dappa, Florian Jungmann, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Hepatobiliary Surgery and Nutrition|June 9, 2020
Systemic therapy without radiation may be appropriate as neoadjuvant therapy for localized pancreas cancerScott Kizy, Ariella M Altman, Keith M Wirth, et al.
Annals of Surgery|April 1, 2020
Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort AnalysisKeith M Wirth, Adam C Sheka, Scott Kizy, et al.
Urology|August 8, 2001
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progressionM Wirth, C Tyrrell, M Wallace, et al.
Der Urologe. Ausg. A|May 8, 1999
[Early recognition of prostate carcinoma. Initial results of a prospective multicenter study in Germany. Project Group for Early Detection DGU-BDU Laboratory diagnosis Professional Circle]H J Luboldt, J E Altwein, K H Bichler, et al.
Molecular Cancer Research : MCR|April 28, 2023
Desmoglein 2 Functions as a Receptor for Fatty Acid Binding Protein 4 in Breast Cancer Epithelial CellsDongmei Chen, Keith M Wirth, Scott Kizy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancerS D Baker, M Wirth, P Statkevich, et al.
Aktuelle Urologie|May 31, 2006
[Interdisciplinary recommendations concerning the therapy for hormone-refractory prostatic carcinoma]K Miller, K Becker, F Finke, et al.
Pageof 34